4//SEC Filing
Simpson Robert Arthur 4
Accession 0001140361-18-033099
CIK 0001275187other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 9:43 PM ET
Size
9.8 KB
Accession
0001140361-18-033099
Insider Transaction Report
Form 4
Simpson Robert Arthur
SVP/GM, Global Vascular
Transactions
- Award
Common Stock
2018-07-18+4,748→ 17,431 total - Award
Non-Qualified Stock Option (right to buy)
2018-07-18+15,126→ 15,126 totalExercise: $20.93From: 2019-07-18Exp: 2028-07-18→ Common Stock (15,126 underlying) - Award
Performance Right
2018-07-18+9,496→ 9,496 total→ Common Stock (9,496 underlying)
Footnotes (3)
- [F1]This acquisition of 4,748 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 4,748 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022.
- [F2]These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022.
- [F3]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001706163
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 9:43 PM ET
- Size
- 9.8 KB